---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-113159"
form_type: "8-K"
ticker: "NEOG"
cik: "0000711377"
company_name: "NEOGEN CORP"
filed_at: "2022-04-21T23:59:59+00:00"
generated_at: "2026-06-26T05:54:19.262613+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Neogen appoints Doug Jones as COO; VP Genomics Marylinn Munson departs

## Summary
- Doug Jones named Chief Operating Officer, a newly created role overseeing worldwide revenues and operations.
- Dr. Jason Lilly assumes interim responsibility for North American genomics operations.
- Marylinn Munson, former Vice President of Genomics, has left the company.
- Jerome Hagedorn (VP North American Operations) and Dr. Lilly will report to Jones; Jones reports to CEO John Adent.

## SEC filing metadata
- accession: 0001193125-22-113159
- form_type: 8-K
- ticker: NEOG
- cik: 0000711377
- company_name: NEOGEN CORP
- filed_at: 2022-04-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711377/000119312522113159/0001193125-22-113159-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711377/000119312522113159/d317850d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-113159
- JSON: https://secwatch.observer/filing/0001193125-22-113159.json
- Plain text: https://secwatch.observer/filing/0001193125-22-113159.txt

## Key facts
- Executive change
  Doug Jones was named as Chief Operating Officer at NEOGEN CORP.
  - Action: named
  - Role: Chief Operating Officer
  source text: On April 19, 2022, Neogen Corporation (the “Registrant”) announced that Doug Jones was named Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/711377/000119312522113159/0001193125-22-113159-index.htm
- Executive change
  Marylinn Munson departed as Vice President, Genomics at NEOGEN CORP.
  - Action: left
  - Role: Vice President, Genomics
  source text: Marylinn Munson, former Vice President, Genomics, has left the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/711377/000119312522113159/0001193125-22-113159-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.